Verified Nov 2026
Other
·
Ottignies-Louvain-la-Neuve, Walloon Region
·
Since 1986
IBA, founded in 1986 and headquartered in Ottignies-Louvain-la-Neuve, Belgium, designs and manufactures particle accelerator systems for medical and industrial applications. The company, with 1,000–5,000 employees and annual revenue between $500 million and $1 billion, serves the oncology, medical device, and industrial sterilization sectors. IBA's proton therapy systems are installed at over 62 medical institutions globally, and the company recently secured a contract to establish a proton therapy center in Rome.
IBA at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1986
Headquarters
Ottignies-Louvain-la-Neuve, Walloon Region
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
IBA, founded in 1986 and headquartered in Ottignies-Louvain-la-Neuve, Belgium, designs and manufactures particle accelerator systems for medical and industrial applications. The company, with 1,000–5,000 employees and annual revenue between $500 million and $1 billion, serves the oncology, medical device, and industrial sterilization sectors. IBA's proton therapy systems are installed at over 62 medical institutions globally, and the company recently secured a contract to establish a proton therapy center in Rome.
At a glance
Attribute | Detail |
|---|---|
Founded | 1986 |
Headquarters | Ottignies-Louvain-la-Neuve, Walloon Region |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What IBA makes
The company supplies proton therapy systems, dosimetry solutions for patient safety, radiopharmaceutical products, and industrial sterilization equipment to hospitals, cancer centers, and medical device manufacturers.
Latest developments
2026-10-23 — IBA signs major contract for a high-throughput Be Efficient sterilization solution in Germany | IBA Group (iba-worldwide.com)
2026-09-29 — IBA signs contract to install the first proton therapy center in central Italy, in Rome | IBA Group (iba-worldwide.com)
2026-04-14 — New Investment: IBA Group | bd-capital | Operator-Led Private Equity (bd-cap.com)
2026-03-27 — IBA delivers strong FY 2025 results with solid execution in all segments | IBA Group (iba-worldwide.com)
2026-02-04 — New IBA & STS Collaboration (shannontechnicalservices.com)
2026-01-19 — IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems | IBA Group (iba-worldwide.com)
Company details
Over 62 renowned medical institutions worldwide operate particle therapy centers equipped with IBA systems. IBA was founded in 1986, has an estimated 1,000-5,000 employees, and is headquartered in Ottignies-Louvain-la-Neuve, Walloon Region.
Frequently asked questions
What does IBA do?
IBA, founded in 1986 and headquartered in Ottignies-Louvain-la-Neuve, Belgium, designs and manufactures particle accelerator systems for medical and industrial applications. The company, with 1,000–5,000 employees and annual revenue between $500 million and $1 billion, serves the oncology, medical device, and industrial sterilization sectors. IBA's proton therapy systems are installed at over 62 medical institutions globally, and the company recently secured a contract to establish a proton therapy center in Rome.
Where is IBA headquartered?
IBA is headquartered in Ottignies-Louvain-la-Neuve, Walloon Region (Chemin du Cyclotron, Ottignies-Louvain-la-Neuve, Walloon Region, 1348).
When was IBA founded?
IBA was founded in 1986.
How big is IBA?
IBA has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
